This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK (
CHANGE IN RATINGSArch Coal(ACI) was upgraded at Goldman Sachs from Sell. Valuation call, based on an $8 price target, Goldman said.
Assured Guaranty(AGO) was upgraded at UBS to Buy from Neutral. $18 price target. Favorable risk/reward, UBS said.
Alere(ALR) was downgraded at Capstone Investments from Buy to Hold. Company lacks near-term visibility, Capstone said.
Aeropostale(ARO - Get Report) was upgraded at Wells Fargo to Market Perform. Business trends appear to be improving, Wells Fargo said.
Baker Hughes(BHI) was downgraded at Societe Generale from Buy to Hold. $47 price target. Company is seeing lower margins in North America, Societe Generale said.
CACI was upgraded from Underweight to Neutral at JP Morgan. $52 price target. Stock has declined 29% since earnings, JP Morgan said.
Carefusion(CFN) was upgraded at CLSA from Outperform to Buy. Expect strong 2013 guidance from management, CLSA said. $30 price target.
Cinemark(CNK) was initiated with a Buy rating at Wunderlich. Valuation call, based on a $30 price target.
Duke Energy(DUK - Get Report) was upgraded at UBS to Buy from Neutral. $24 price target. Consolidated company creates scale and value creation potential, UBS said.
Eaton Vance(EV) was upgraded at Citigroup to Neutral from Sell. $23.50 price target. Shares approaching appropriate valuation, Citi said.
Express(EXPR - Get Report) was initiated with a Neutral rating at JP Morgan. $20 price target. Company lacks near-term catalysts, JP Morgan said.
1-800-Flowers(FLWS) was upgraded to Buy at TheStreet Ratings.
Forum Energy(FET) was initiated with a Buy rating at Deutsche Bank. $30 price target. Company is leveraged to strong secular growth markets, Deutsche said.
Green Dot(GDOT) was downgraded at Morgan Stanley from Overweight to Equal-weight. $25 price target. Company is facing regulatory and competitive pressures, Morgan Stanley said.
Heico(HEI) was upgraded at Bank of America/Merrill Lynch to Buy. Valuation call, based on a $54 price target, BofA/Merrill said.
Human Genome(HGSI) was downgraded at BMO Capital to Market Perform. $13 price target. GSK may drop its bid for the company, BMO Capital said.
Hyatt Hotels Corp.(H) was downgraded to Hold at TheStreet Ratings.
Knight Transportation(KNX) was upgraded at Sterne Agee. $17 price target. Estimates were also increased, as the company should perform better over the coming quarters, Sterne Agee said.